Sharma N C, Banavaliker J N, Ranjan Rajesh, Kumar Rajnish
Laboratory Department, Maharishi Valmiki Infectious Diseases Hospital, Delhi, India.
Indian J Med Res. 2007 Dec;126(6):545-52.
BACKGROUND & OBJECTIVE: Diphtheria infections caused by the different toxigenic biotypes of Corynebacterium diphtheriae are endemic in Delhi. Information on biochemical identification, toxigenicity and antimicrobial susceptibility to this bacterium is scanty. This retrospective study was carried out to identify isolated Corynebacteria biochemically, determine their toxigenicity, drug sensitivity and some epidemiological characteristics of diphtheria cases from Delhi and adjoining States for the period 1998-2004.
A total of 1118 throat and 585 nasal swabs were used to detect human pathogenic corynebacteria. WHO recommended methods were used for the detection, screening, toxigenicity and antibiogram pattern of the isolates.
Among 493 (44.1%) cases detected positive for corynebacteria 71.8 per cent were pharyngeal, 20.9 per cent nasopharyngeal and rest 7.3 per cent nasal diphtheria cases. Biochemical identification revealed two species i.e., C. diphtheriae and C. pseudodiphtheriticum. In C. diphtheriae three biotypes were detected viz., intermedius (95.5%), gravis (3.4%) and mitis (1.1%). Toxin was expressed by 96 per cent isolates of C. diphtheriae. Cases were recorded from Delhi and four adjoining States. Sex ratio among male to female was 1.6:1. Prime victims were less than 9 yr old children (93.3%). Unvaccinated children (70.2%) were the main sufferers. Fatality rate was highest in Delhi cases (16.8%) followed by UP (14.6%) and Haryana (5.9%).
INTERPRETATION & CONCLUSION: Standard methods revealed the replacement of C. diphtheriae var mitis with var intermedius and occurrence of diphtheria infections due to other human pathogenic corynebacteria. It is imperative to have good bacteriological facilities to have better surveillance with regular monitoring in the endemic areas to keep the disease under control.
由白喉棒状杆菌不同产毒株生物型引起的白喉感染在德里呈地方流行。关于该细菌的生化鉴定、产毒性及抗菌药物敏感性的信息匮乏。开展这项回顾性研究以对分离出的棒状杆菌进行生化鉴定,确定其产毒性、药物敏感性以及1998 - 2004年期间德里及周边邦白喉病例的一些流行病学特征。
共使用1118份咽拭子和585份鼻拭子检测人类致病性棒状杆菌。采用世界卫生组织推荐的方法对分离株进行检测、筛查、产毒性及抗菌谱模式分析。
在493例(44.1%)棒状杆菌检测呈阳性的病例中,71.8%为咽白喉,20.9%为鼻咽白喉,其余7.3%为鼻白喉病例。生化鉴定显示有两种菌,即白喉棒状杆菌和假白喉棒状杆菌。在白喉棒状杆菌中检测到三种生物型,即中间型(95.5%)、重型(3.4%)和轻型(1.1%)。96%的白喉棒状杆菌分离株产毒。病例来自德里及四个周边邦。男女比例为1.6:1。主要受害者为9岁以下儿童(93.3%)。未接种疫苗的儿童(70.2%)是主要患病者。德里病例死亡率最高(16.8%),其次是北方邦(14.6%)和哈里亚纳邦(5.9%)。
标准方法显示轻型白喉棒状杆菌已被中间型取代,且存在由其他人类致病性棒状杆菌引起的白喉感染。在地方流行区必须具备良好的细菌学设施,以便通过定期监测进行更好的监测,从而控制该疾病。